LIGAND PHARMACEUTICALS INCORPORATED
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $-4.9M | $3.3M |
| FY2011 | — | $8.2M | $7.0M |
| FY2012 | $27.5M | $26.5M | $12.4M |
| FY2013 | — | $49.6M | $11.6M |
| FY2014 | — | $26.3M | $160.2M |
| FY2015 | — | $237.3M | $97.4M |
| FY2016 | — | $341.3M | $18.8M |
| FY2017 | — | $399.8M | $20.6M |
| FY2018 | — | $560.9M | $117.2M |
| FY2019 | — | $767.2M | $71.5M |